Drugs / LOC-paclitaxel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01039844 | Dec 2009 → Feb 2016 | melanoma | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LOC-paclitaxel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01039844 ↗ |
| Route | Intravenous | “LOC-paclitaxel IV by a 1 hour infusion” NCT01039844 ↗ |